Cytokinetics reported $-19820000 in Pre-Tax Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.57M 79M
Biogen BIIB:US $ 874.8M 28.6M
Brainstorm Cell Therapeutics BCLI:US $ -7.04M 1.68M
Capricor Therapeutics CAPR:US $ -7.11M 0.71M
Cytokinetics CYTK:US $ -19.82M 66.93M
Eisai 4523:JP Y 9722M 30501M
Exelixis EXEL:US $ 88.51M 3.28M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Geron GERN:US $ -28.12M 1.98M
Halozyme Therapeutics HALO:US $ 30.01M 51.62M
Novartis NOVN:VX SF 4129M 217M
Sanofi SAN:FP € 2660M 305M